ľֱ

Statins and CKD; Farxiga's Limited Symptom Improvement; Stop Wasted TNKase

— Recent developments of interest in cardiovascular medicine

MedpageToday
Cardio Break over a computer rendering of a heart.

The was an estimated 9.7% around the world, reaching a high of 14.5% in South-Central Asia. (European Journal of Preventive Cardiology)

did not improve the performance of the pooled cohort risk equations in the prospective REGARDS cohort. (JAMA Cardiology)

Older veterans with stage 3-4 chronic kidney disease and no history of atherosclerotic cardiovascular disease had lower odds of poor clinical events if they . (JAMA Network Open)

A woman diagnosed with was able to get pregnant and give birth without angina attacks after initiating diltiazem therapy. (JACC: Case Reports)

The SGLT2 inhibitor dapagliflozin (Farxiga) showed that its may be limited to heart failure patients with reduced ejection fraction in the DETERMINE trials. (Circulation)

For patients admitted to , a retrospective analysis showed no unexpected deaths and the most common reason for escalation was progressive renal dysfunction. (Circulation: Cardiovascular Quality and Outcomes)

Across countries, spouses in the same household often share . (Journal of the American Heart Association)

Getinge's is under class I recall due to an issue with the hand crank getting stuck, the FDA alerted.

Given that tenecteplase is only available in 50-mg vials, it is feasible to for treating stroke in order to reduce waste, one hospital found. (Stroke)

COVID pandemic waves were not accompanied by , according to records from the Midi-Pyrénées area of France. (EP Europace)

Warfarin was associated with fewer thromboembolic events after , albeit at the cost of more major bleeding. (Mayo Clinic Proceedings)

makes a difference in outcomes after mitral transcatheter edge-to-edge repair, one high-volume center found. (JACC: Cardiovascular Interventions)

A was developed to quickly harden into a desired 3D structure in deep tissues with high spatial precision, with potential applications in left atrial appendage occlusion and heart valve repair. (Science)

, of Yale School of Medicine, was named the new editor-in-chief of the Journal of the American College of Cardiology.

  • author['full_name']

    Nicole Lou is a reporter for ľֱ, where she covers cardiology news and other developments in medicine.